Search company, investor...

Smart Pharma


Acquired | Acquired

Total Raised


About Smart Pharma

Smart Pharma produces and sells drugs and medical products. The company also provides services to other companies in the industry. Smart Pharma's products include Innofer, Innofer Baby and Diflos (a probiotic containing strains of bacteria). On September 17th, 2020, Smart Pharma was acquired by Chiesi, terms of the transaction were not disclosed.

Headquarters Location


Suchy Las, 62-002,


+48 61 659 38 65

Missing: Smart Pharma's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Smart Pharma's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Smart Pharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Smart Pharma is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Latest Smart Pharma News

Smart Pharma Thematic Research Report 2021: The Importance of Artificial Intelligence and Big Data -

Jul 16, 2021

July 16, 2021 09:39 AM Eastern Daylight Time This Smart Pharma report examines the integration of smart technologies across the pharmaceutical industry value chain, assesses COVID-19 impact on the uptake of smart technologies in pharma and importance of partnering with technology vendors to enable a roll-out of innovative technologies. The COVID-19 pandemic has given businesses an unprecedented opportunity to accelerate and implement technology-fueled changes to the way they operate. Even though digital transformation and smart technologies uptake had already begun pre-pandemic, COVID-19 made this process even more pressing. While in the past the pharmaceutical sector used to display a more conservative stance toward the adoption of new technologies, the COVID-19 pandemic was a major catalyst for the industry to rethink and redefine their operations and embrace digital transformation at a faster pace. For pharmaceutical companies, the pandemic forced many to rethink and readjust their drug development process, manufacturing, supply chains, marketing strategies, and end-customer reach. Although pharmaceutical companies mainly relied on technologies before the pandemic to enhance internal processes, now digital technologies are becoming necessary to ensure business continuity and to gain competitive edge. Scope A total of 155 of the publisher's Pharma clients and prospects participated in the 10-minute survey, which was fielded from April 21, 2021 to May 18, 2021. In this report, smart pharma refers to the incorporation of new technologies to improve and enhance processes such as drug development, manufacturing, supply chains, and sales and marketing. Components of the report include: Adoption of Smart Technologies in Pharma - highlights the main challenges and benefits associated with implementation of smart technologies within the pharmaceutical industry providing respondent mix by region, and company size. Drug Discovery and Development - assesses the smart technologies that are expected to play a major role in optimizing drug discovery and development process and highlights the current and future technologies uptake. Manufacturing - examines the smart technologies that are expected to play a major role in optimizing pharmaceutical manufacturing process and highlights the current and future technologies uptake. Supply Chains - evaluates the smart technologies that are expected to play a major role in optimizing supply chains and highlights the current and future technologies uptake. Sales and marketing - assesses the smart technologies that are expected to play a major role in optimizing sales and marketing process and highlights the current and future technologies uptake. Pharma and Tech Collaborations - showcases how pharmaceutical industry is partnering with external technology vendors to increase the implementation speed, efficiency, and reliability of new technologies. A Closer Look at Big Data and AI - highlights the importance of Artificial Intelligence and Big Data in pharmaceutical industry. COVID-19 Impact - assesses the COVID-19 impact on the acceleration of smart technologies uptake. Key Topics Covered:

Smart Pharma Frequently Asked Questions (FAQ)

  • Where is Smart Pharma's headquarters?

    Smart Pharma's headquarters is located at Zlotniki, Suchy Las.

  • What is Smart Pharma's latest funding round?

    Smart Pharma's latest funding round is Acquired.

  • How much did Smart Pharma raise?

    Smart Pharma raised a total of $400K.

  • Who are the investors of Smart Pharma?

    Investors of Smart Pharma include Chiesi Farmaceutici, SpeedUp Venture Capital Group and YouNick.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.